Printer Friendly

2,250,000 SHARES OF RIBI IMMUNOCHEM COMMON STOCK OFFERED AT $6 PER SHARE

 HAMILTON, Mont., Oct. 22 /PRNewswire/ -- Ribi ImmunoChem Research, Inc. (NASDAQ-NMS: RIBI), announced today a second public offering of 2,250,000 shares of common stock priced at $6 per share. All the shares were offered by the company. The offering was underwritten by Hambrecht & Quist Incorporated. The company has granted to Hambrecht & Quist Incorporated a 30-day option to purchase up to 337,500 additional shares solely to cover over-allotments.
 Ribi ImmunoChem Research, Inc., is developing products believed to stimulate the immune system to generate a cascade of natural agents to treat and prevent human disease. Ribi immunostimulants are designed to be combined with disease-specific antigens to direct the immune system to respond to a particular cancer or infectious disease or to be used to produce a generalized immune response to prevent conditions such as septic shock and post-ischemic reperfusion injury.
 A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on Oct. 22, 1993. This announcement shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there by any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering is made only by the prospectus.
 Copies of the prospectus relating to the offering may be obtained from Hambrecht & Quist Incorporated, One Bush Street, 18th Floor, San Francisco, Calif. 94104, 415-576-3423.
 -0- 10/22/93
 /CONTACT: Ronald H. Kullick, vice president - legal counsel of Ribi ImmunoChem Research, 406-363-6214, ext. 113/
 (RIBI)


CO: Ribi ImmunoChem Research, Inc. ST: Montana IN: MTC SU: OFR

TW -- NY040 -- 5728 10/22/93 12:22 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 22, 1993
Words:289
Previous Article:SWANK, INC. REPORTS RESULTS FOR THIRD QUARTER AND NINE MONTHS
Next Article:DEXTER DECLARES QUARTERLY DIVIDEND
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters